P
TMDX icon

Pitcairn’s Transmedics TMDX Stock Holding History

Pitcairn’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,661
Closed -$411K – 526
2025
Q3 		$411K Sell
3,661
-1,151
-24% -$135K 0.03% 402
2025
Q2 		$645K Sell
4,812
-906
-16% -$99.5K 0.04% 354
2025
Q1 		$385K Buy
5,718
+72
+1% +$4.95K 0.02% 508
2024
Q4 		$352K Buy
5,646
+1,653
+41% +$154K 0.02% 537
2024
Q3 		$627K Sell
3,993
-2,063
-34% -$318K 0.04% 368
2024
Q2 		$912K Buy
6,056
+678
+13% +$81.3K 0.06% 290
2024
Q1 		$398K Buy
5,378
+78
+1% +$6.43K 0.03% 495
2023
Q4 		$418K Sell
5,300
-35
-0.7% -$2.11K 0.03% 449
2023
Q3 		$292K Sell
5,335
-1,277
-19% -$91.9K 0.02% 508
2023
Q2 		$555K Buy
+6,612
New +$506K 0.05% 327

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Pitcairn's TMDX Position: Q4 2025 in Review

Pitcairn sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 3,661 shares — an estimated $411K sold.

Pitcairn first reported a position in TMDX in Q2 2023 and held it in 10 quarters. The position peaked at $912K in Q2 2024. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Pitcairn reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 3,661 Transmedics shares in Q4 2025, an estimated $411K.
  • Pitcairn first reported a position in Transmedics in Q2 2023 and held it in 10 quarters.
  • Pitcairn's Transmedics position peaked at $912K in Q2 2024.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.